Moelis Reiterates Buy Rating for Alexium and Price Target of $1.20
(firmenpresse) - PERTH, AUSTRALIA and GREER, SC -- (Marketwired) -- 05/10/16 --
(Alexium) (ASX: AJX) (OTCQX: AXXIY) The Company has announced that Moelis Securities Pty Ltd., issued a report on 10 May on Alexium, updating estimates to reflect recent Company developments including the announcement of success and further expansion into the coatings and polymer market.
"The Moelis rating of ''buy'' with a 12 month price target of $1.20 is recognition of Alexium''s significant presence in the market," said Nicholas Clark, Alexium CEO. "We remain on track for our mid-year and year-end goals."
The Moelis report can be accessed by visiting and selecting "Investors" and then "Investor Research."
Moelis and Company is a global independent investment bank that provides financial advisory services to corporations, governments and financial sponsors. The firm advisors on strategic decisions such as mergers and acquisitions, recapitalizations and restructurings and other corporate finance matters. Moelis was founded in 2007 and is headquartered in New York, with 17 offices in North and South America, Europe, the Middle East, Asia and Australia. It has 650 employees including 450 investment bankers.
Alexium International Group Limited (ASX: AJX, AX:AJX OTC QX: AXXIY) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium''s fire retardant chemical treatments are currently marketed for different fabric markets under the Alexiflam™, Ascalon™, Nycolon™, Nuvalon™, and Polytron™, Omnitron™ and Bactron™ trademarks. For additional information about Alexium, please visit .
U. S. Corporate Offices:
1100 New York Avenue, Suite 710W
Washington DC 20001
148 Milestone Way, Suite B,
Greenville, SC 29615
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 10.05.2016 - 16:59 Uhr
Sprache: Deutsch
News-ID 1434089
Anzahl Zeichen: 2893
contact information:
Contact person:
Town:
PERTH, AUSTRALIA and GREER, SC
Phone:
Kategorie:
Aircraft
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 239 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Moelis Reiterates Buy Rating for Alexium and Price Target of $1.20
"
steht unter der journalistisch-redaktionellen Verantwortung von
Alexium International (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
